These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 15356141)

  • 1. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination.
    Nussbaum AK; Rodriguez-Carreno MP; Benning N; Botten J; Whitton JL
    J Immunol; 2005 Jul; 175(2):1153-60. PubMed ID: 16002717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An altered T cell repertoire in MECL-1-deficient mice.
    Basler M; Moebius J; Elenich L; Groettrup M; Monaco JJ
    J Immunol; 2006 Jun; 176(11):6665-72. PubMed ID: 16709825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
    Sijts AJ; Standera S; Toes RE; Ruppert T; Beekman NJ; van Veelen PA; Ossendorp FA; Melief CJ; Kloetzel PM
    J Immunol; 2000 May; 164(9):4500-6. PubMed ID: 10779750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
    Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
    J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells.
    Butz EA; Bevan MJ
    J Immunol; 1998 Mar; 160(5):2139-44. PubMed ID: 9498751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.
    Khan S; van den Broek M; Schwarz K; de Giuli R; Diener PA; Groettrup M
    J Immunol; 2001 Dec; 167(12):6859-68. PubMed ID: 11739503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.
    Towne CF; York IA; Watkin LB; Lazo JS; Rock KL
    J Immunol; 2007 Jun; 178(11):6923-30. PubMed ID: 17513741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation.
    van der Most RG; Murali-Krishna K; Lanier JG; Wherry EJ; Puglielli MT; Blattman JN; Sette A; Ahmed R
    Virology; 2003 Oct; 315(1):93-102. PubMed ID: 14592762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
    van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
    J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
    Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
    J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression.
    Probst HC; Tschannen K; Gallimore A; Martinic M; Basler M; Dumrese T; Jones E; van den Broek MF
    J Immunol; 2003 Nov; 171(10):5415-22. PubMed ID: 14607945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.
    Gavioli R; Gallerani E; Fortini C; Fabris M; Bottoni A; Canella A; Bonaccorsi A; Marastoni M; Micheletti F; Cafaro A; Rimessi P; Caputo A; Ensoli B
    J Immunol; 2004 Sep; 173(6):3838-43. PubMed ID: 15356131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.
    Gallimore A; Schwarz K; van den Broek M; Hengartner H; Groettrup M
    Mol Immunol; 1998 Jul; 35(10):581-91. PubMed ID: 9823757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.